21 CFR 660.54 – Potency tests, specificity tests, tests for heterospecific antibodies, and additional tests for nonspecific properties
Current as of: 2024 | Check for updates
|
Other versions
The following tests shall be performed using test procedures approved by the Director, Center for Biologics Evaluation and Research:
(a) Potency tests for determining anti-IgG and anti-complement activity.
(b) Specificity tests, tests for heterospecific antibodies, and additional tests for nonspecific properties.